Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Capsugel CEO Driesen Plots Post-Pfizer Course

This article was originally published in The Tan Sheet

Executive Summary

Guido Driesen, president and CEO of Capsugel, says the oral dosage technology firm is having a record year after being divested by Pfizer. In an interview, he discusses the firm’s applications for OTC drugs and nutritionals, as well as Capsugel’s international expansion.

Advertisement

Related Content

New Parent Lonza Welcomes Capsugel's Independent Streak To Innovate
New Parent Lonza Welcomes Capsugel's Independent Streak To Innovate
Capsugel Flexes Breadth Of Capabilities In Development Collaborations
Capsugel Flexes Breadth Of Capabilities In Development Collaborations
Capsugel Strives To Deliver Growth And Innovation Via New Unit, Execs
Capsugel Strives To Deliver Growth And Innovation Via New Unit, Execs
Nestle Pays Nearly $12 Bil. For Desirable Pfizer Nutrition Portfolio
Nestle Pays Nearly $12 Bil. For Desirable Pfizer Nutrition Portfolio
Pfizer Sells Nutrition Portfolio To Nestle For Nearly $12B, Widening Nestle’s Reach In Emerging Markets
Freed From Pfizer, Capsugel May Find More Market Opportunities

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel